Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

Completed · Phase 3 · Has a placebo group

Conditions studied: Pain, Inflammation, Cataract

In brief

This is an efficacy study of Bromfenac Ophthalmic Solution in cataract surgery.

Key facts

Study ID

NCT01367249

Run by

Bausch & Lomb Incorporated

People needed

440

Starts

2011-05-01

Expected to finish

2011-12-01

Last updated by the study team

2014-05-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female at least 18 years of age who are scheduled for unilateral cataract surgery

You may not qualify if…

• Have known hypersensitivity to bromfenac or to any component of the investigational product

Where it is running

• ISTA Pharmaceuticals, Inc. — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.